Kimberly-Clark is buying Tylenol maker Kenvue in a $48.7 billion cash-and-stock deal, creating a massive consumer health ...

The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a ...

The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven ...

The agreement, which combines the maker of Huggies diapers with the owner of the painkiller brand, will create a global ...

Kimberly-Clark is laying down $40 billion to buy Kenvue in a massive deal that has puzzled some investors as the Tylenol ...

Kimberly-Clark Corp. will acquire Tylenol maker Kenvue Inc. in a cash and stock deal valued at almost $49 billion the two ...

Kimberly-Clark está comprando al fabricante de Tylenol, Kenvue, en un acuerdo de efectivo y acciones valorado en ...

Clark’s stock continued for a second day and raised the prospect that an activist investor could surface and try to block its ...

Mike Hsu aims to stoke the consumer company’s growth by veering into Kenvue’s higher-margin but risky health products.

Kimberly-Clark is making a big move with a nearly $50 billion acquisition. The North Texas company plans to acquire Kenvue ...

Kimberly-Clark's nearly $50 billion offer for Tylenol maker Kenvue is a risky bet that the world's biggest consumer market, ...

One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common ...